{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:09:38Z","timestamp":1789391378740,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Major Project of China","award":["No.2013ZX0004003004"],"award-info":[{"award-number":["No.2013ZX0004003004"]}]},{"name":"National 863 Plan of China","award":["No.2012AA02A406"],"award-info":[{"award-number":["No.2012AA02A406"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0169501","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T22:39:17Z","timestamp":1484001557000},"page":"e0169501","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59"],"prefix":"10.1371","volume":"12","author":[{"given":"Shu-Ting","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Juan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/CVI.00615-13","article-title":"Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly","volume":"21","author":"YB Seo","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"ref2","first-page":"w13940","article-title":"Vaccine adjuvants\u2014understanding molecular mechanisms to improve vaccines","volume":"144","author":"A Egli","year":"2014","journal-title":"Swiss Med Wkly"},{"issue":"25\u201326","key":"ref3","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/S0264-410X(03)00381-5","article-title":"Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion","volume":"21","author":"A Myc","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jcph.299","article-title":"Seasonal influenza vaccination and technologies","volume":"54","author":"AN Nafziger","year":"2014","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"e0137608","DOI":"10.1371\/journal.pone.0137608","article-title":"Inactivated Eyedrop Influenza Vaccine Adjuvanted with Poly(I:C) Is Safe and Effective for Inducing Protective Systemic and Mucosal Immunity","volume":"10","author":"ED Kim","year":"2015","journal-title":"PLoS One"},{"issue":"4 Suppl","key":"ref6","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"J Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.it.2004.09.005","article-title":"Let's go mucosal: communication on slippery ground","volume":"25","author":"P Brandtzaeg","year":"2004","journal-title":"Trends Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"471468","DOI":"10.1155\/2015\/471468","article-title":"Cholesteryl Pullulan Encapsulated TNF-alpha Nanoparticles Are an Effective Mucosal Vaccine Adjuvant against Influenza Virus","volume":"2015","author":"D Nagatomo","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1586\/erv.12.31","article-title":"Mucosal immunity and nasal influenza vaccination","volume":"11","author":"MA Rose","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"13\u201314","key":"ref10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0264-410X(00)00358-3","article-title":"Ensuring vaccine safety in immunization programmes\u2014a WHO perspective","volume":"19","author":"L Jodar","year":"2001","journal-title":"Vaccine"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4161\/hv.29609","article-title":"Mucosal immunization in perspective","volume":"10","author":"MA Rose","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/rmv.398","article-title":"New generation of mucosal adjuvants for the induction of protective immunity","volume":"13","author":"Y Yuki","year":"2003","journal-title":"Rev Med Virol"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"RB Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7883\/yoken.63.8","article-title":"Estimation of the effective doses of nasal-inactivated influenza vaccine in humans from mouse-model experiments","volume":"63","author":"S Tamura","year":"2010","journal-title":"Jpn J Infect Dis"},{"issue":"9","key":"ref15","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"FW van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0956462413496771","article-title":"Polyactin A increases CD4(+) T-cell counts in HIV-infected individuals with insufficient immunologic response to highly active antiretroviral therapy","volume":"25","author":"QJ Su","year":"2014","journal-title":"Int J STD AIDS"},{"issue":"Suppl 1","key":"ref17","first-page":"204","article-title":"Experimental research on immunological activity of Polyactin A","volume":"24","author":"XY Zeng","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3","key":"ref18","first-page":"230","article-title":"Curative effect observation of polyactin A on enhancing antibody production of hepatitis B vaccine recipients","volume":"29","author":"R Liu","year":"2006","journal-title":"BMC Journal"},{"issue":"5","key":"ref19","first-page":"604","article-title":"Immunologic effects of mannatide as a new adjuvant of H1N1 split vaccine","volume":"34","author":"SL Feng","year":"2013","journal-title":"Journal of Xi'an Jiaotong University(Medical Science)"},{"issue":"11","key":"ref20","first-page":"1435","article-title":"Immunization response of enterovirus 71 whole virus inactivation antigen combined with PA adjuvant by nasal mucosa in mice","volume":"33","author":"J Jing","year":"2013","journal-title":"Basic & Clinical Medicine"},{"issue":"7\u20138","key":"ref21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0264-410X(98)00252-7","article-title":"The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice","volume":"17","author":"GL Barchfeld","year":"1999","journal-title":"Vaccine"},{"issue":"20","key":"ref22","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1016\/j.vaccine.2003.12.018","article-title":"Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine","volume":"22","author":"E Greenbaum","year":"2004","journal-title":"Vaccine"},{"issue":"8","key":"ref23","first-page":"799","article-title":"Influence of Polyactin A on lymphocyte immune activity of ROU patient","volume":"27","author":"XP Ji","year":"2006","journal-title":"Sichuan Medical Journal"},{"issue":"10","key":"ref24","first-page":"72","article-title":"Immune modulatory and therapeutic effect of Mannatide Capsules on perennial allergic rhinitis","volume":"6","author":"J Zhang","year":"2009","journal-title":"China Medical Herald"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4161\/hv.25458","article-title":"Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults","volume":"9","author":"A Ainai","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"S Tamura","year":"2005","journal-title":"Jpn J Infect Dis"},{"issue":"38","key":"ref27","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1016\/j.vaccine.2010.05.019","article-title":"Studies on the usefulness of intranasal inactivated influenza vaccines","volume":"28","author":"S Tamura","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jmv.20173","article-title":"Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus","volume":"74","author":"Y Asahi-Ozaki","year":"2004","journal-title":"J Med Virol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"KB Renegar","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2567.2004.01958.x","article-title":"IgA function\u2014variations on a theme","volume":"113","author":"JM Woof","year":"2004","journal-title":"Immunology"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"JE McElhaney","year":"2006","journal-title":"J Immunol"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"S Sridhar","year":"2013","journal-title":"Nat Med"},{"key":"ref33","article-title":"Evaluation of influenza vaccine-immunogenicity in cell-mediated immunity","author":"N Otani","year":"2016","journal-title":"Cell Immunol"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.4049\/jimmunol.159.7.3453","article-title":"Influenza infection of beta 2-microglobulin-deficient (beta 2m-\/-) mice reveals a loss of CD4+ T cell functions with aging","volume":"159","author":"SF Taylor","year":"1997","journal-title":"J Immunol"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.vaccine.2007.11.054","article-title":"Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice","volume":"26","author":"A Wack","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/cimm.1996.0252","article-title":"Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A","volume":"173","author":"IN Mbawuike","year":"1996","journal-title":"Cell Immunol"},{"issue":"Suppl 1","key":"ref37","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.vaccine.2005.04.019","article-title":"The unmet need in the elderly: designing new influenza vaccines for older adults","volume":"23","author":"JE McElhaney","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"WW Thompson","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"WW Thompson","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7774\/cevr.2014.3.2.194","article-title":"Assessment of mOMV adjuvant efficacy in the pathogenic H1N1 influenza virus vaccine","volume":"3","author":"BJ Lee","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"issue":"1\u20132","key":"ref41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2014.04.003","article-title":"A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation","volume":"468","author":"J Deng","year":"2014","journal-title":"Int J Pharm"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"19570","DOI":"10.1038\/srep19570","article-title":"Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens","volume":"6","author":"NP Knudsen","year":"2016","journal-title":"Sci Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0169501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T17:59:25Z","timestamp":1718992765000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0169501"}},"subtitle":[],"editor":[{"given":"Victor C.","family":"Huber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0169501","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,4]]}}}